Royalty Pharma Plc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2026 to a ratio of 0.61, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Royalty Pharma Plc in Mar 31 2026 quarter, has decreased to 598 days, compared to 608 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 516 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 2749 to 3363.

What is Receivable Turnover Ratio?
What is Royalty Pharma Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RPRX Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	10.97 %	4.78 %	7.9 %	7.71 %	0.05 %
Receivable Turnover Ratio (TTM)	0.61	0.6	0.59	0.58	-
RPRX's Total Ranking	# 3363	# 2749	# 3005	# 3042	#
Accounts Receivable average collection period days	597	613	620	632	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	1.38 %	2.08 %	5.29 %	1.83 %	-4.28 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 168
Healthcare Sector	# 517
Overall Market	# 3363

Receivable Turnover Ratio Statistics
High	Average	Low
5.08	3.22	0.48
(Dec 31 2020)		(Jun 30 2025)

RPRX Company Profile • Back to RPRX Efficiency Comparisons • Compare RPRX Receivables Turnover Ratio to its Competitors

Financial Statements
Royalty Pharma Plc's Accounts Receivable	$ 0 Millions	Visit RPRX's Balance sheet
Royalty Pharma Plc's Sales TTM	$ 2,441 Millions	Visit RPRX's Income Statement
Sources of RPRX's Revenues		Visit RPRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RPRX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RPRX's Growth Rates	RPRX's Roa	RPRX's Inventory Turnover Ratio	RPRX's Dividend Comparisons
RPRX's Profitability Ratios	RPRX's Roi	RPRX's Asset Turnover Ratio	RPRX's Dividend Growth
RPRX's Valuation Ratios	RPRX's Roe	RPRX's Financial Strength Ratios	RPRX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2026

Receivable at quarter ending Mar 31 2026

Date modified: 2026-08-30T15:00:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.